HPLC Method for Analysis of Alfuzosin in Tablet Dosage Form on Primesep 100 Column

https://sielc.com/hplc-determination-of-alfuzosin
⬇ PDF Download

Chromatogram

Description

· HPLC Method for Analysis of Alfuzosin on Primesep 100 Column by SIELC Technologies

Alfuzosin is a medication with the chemical formula C 19 H 27 N 5 O 4 . It is used to treat the signs and symptoms of benign prostatic hyperplasia (BPH), which is an enlarged prostate gland. It doesn’t shrink the prostate but works by relaxing the muscles of the prostate and the bladder, which helps to relieve symptoms like difficulty in starting the flow of urine, weak stream, and the need to urinate often or urgently. You can find detailed UV spectra of Alfuzosin and information about its various lambda maxima by visiting the following link.

Alfuzosin can be retained, and analyzed on a Primesep 100 mixed-mode stationary phase column using an isocratic analytical method with a simple mobile phase of water, Acetonitrile (MeCN), and a Sulfuric acid as a buffer. This analysis method can be detected using UV at 254 nm.

Method Parameters

Mobile PhaseMeCN/H2O – 70/30%
BufferH2SO4 – 0.1%
Flow Rate1.0 ml/min
DetectionUV 254 nm
Peak Retention Time5.86 min
Class of CompoundsDrug
Analyzing CompoundsAlfuzosin

HPLC Column Used

Primesep 100, 4.6 x 150 mm, 5 µm, 100 A, dual ended